Dr. Lucas has 30+ years of clinical experience and education in community and Gerontological nursing, including Teaching Nursing Home, and 20 years of grant-funded research in Gerontology. In 2015 she received the College’s Faculty Researcher of the Year Award at the University.
Her teaching includes undergraduate and graduate courses, as well as supervising research for doctoral students. Her practice focus has been Geriatric nursing and dementia care. She has been a willing mentor to students and faculty, developed home care simulations, and contributed to the 2016 RWJF-NJNI grant, Infusing Population Health Competencies to Transform a BSN Curriculum for the College.
Over 40 publications include: Evaluating clinical practice guidelines; Nursing Home (NH) transition programs; measuring resident/family satisfaction and state report cards; depression and psychological services in LTC. Her research is focused on safety and resident, organizational, and regulatory factors affecting quality in long-term care (LTC); specifically, prescribing patterns, antipsychotic use and resident outcomes (e.g., injuries, mortality, neuropsychiatric symptoms of dementia). She currently studies NH response to regulatory stringency, deficiencies, public reporting and policy changes of the CMS Partnership for improved NH dementia care.
Dr. Lucas has provided consultation to NHs, hospitals, and states on needs of older adults, NH consumer satisfaction, Geriatric nursing for hospitalized elders, and served as an appointed member of NJ Governor’s State Mental Health Facilities Evaluation Task Force, 2012.
A longstanding member of the Gerontological Society of America, she served on the expert panel to develop the CMS Nursing Toolkit (2012-2014) that promotes behavioral health improvement through non-pharmacological interventions.
- Ed.D. Rutgers University GSE, New Jersey
- M.S. Boston College, Massachusetts
- B.S.N. Saint Anselm College, New Hampshire
- Wei, Y-J., Simoni-Wastila, L., Lucas, J.A., Brandt, N. (2016). Fall and fracture risk in nursing home residents with moderate-to-severe behavioral symptoms of Alzheimer's Disease and related dementias initiating antidepressants or antipsychotics. J Gerontol A Biol Sci Med Sci, 2016, Vol. 00, No. 00, 1–8. doi:10.1093/gerona/glw095. Advance Access publication May 31, 2016
- Simoni-Wastila L, Wei YJ, Lucas JA, Brandt N, Moyo P, Huang TY, Franey CS, Harris I.(2016). Mortality Risk of Antipsychotic Dose and Duration in Nursing Home Residents with Chronic or Acute Indications. J Am Geriatr Soc. 2016 May; 64(5):973-80. doi: 10.1111/jgs.14111. Epub 2016 May 10.
- Huang, T-Y., Wei, Y-J., Moyo, P., Harris, I., Lucas, J.A., & Simoni-Wastila, L. (2015). Treated behavioral symptoms and mortality among Medicare nursing home residents with Alzheimer's Disease and related dementias. Journal of the American Geriatrics Society (JAGS), Aug, 2015.DOI: 10.1111/jgs.13606
- Bowblis, J.R., Lucas, J.A., Brunt, C.S. (2015). The effects of antipsychotic quality reporting on antipsychotic and psychoactive medication use. Health Services Research, 50 (4): 1069-1087.
- Lucas, J.A., Chakravarty, S., Bowblis, J., Gerhard, T., Kalay, E., Peak, E.K & Crystal, S. (2014). Antipsychotic medication use in nursing homes: A Proposed measure of quality. Intern J of Geriatr Psych 29(10):1049-1061. DOI: 10.1002/gps.4098.